CN101185719B - Medicinal composition for treating rhinitis and nasosinusitis - Google Patents
Medicinal composition for treating rhinitis and nasosinusitis Download PDFInfo
- Publication number
- CN101185719B CN101185719B CN2006101457626A CN200610145762A CN101185719B CN 101185719 B CN101185719 B CN 101185719B CN 2006101457626 A CN2006101457626 A CN 2006101457626A CN 200610145762 A CN200610145762 A CN 200610145762A CN 101185719 B CN101185719 B CN 101185719B
- Authority
- CN
- China
- Prior art keywords
- weight portion
- pharmaceutical composition
- weight
- rhinitis
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a pharmaceutical composition for the treatment of rhinitis and sinusitis, the pharmaceutical composition mainly comprises siberian cocklour fruit, biond magnolia flower, scorpion, stiff silkworm, manchurian wildginger, wrinkled gianthyssop herb, Chinese Paris rhizome, common andrographis herb and dahurian angelica root. The pharmaceutical composition of the invention has significant effects for the treatment rhinitis, sinusitis and allergic rhinitis without side effects.
Description
Technical field
The present invention relates to a kind of pharmaceutical composition, particularly relate to a kind of pharmaceutical composition for the treatment of rhinitis, sinusitis.
Background technology
The rhinitis disease is a kind of common disease, easily raises difficult questions and controls.Its sickness rate height, the course of disease time is long, if malpractice or delay treatment, grievous injury human body throat trachea, pulmonary, heart reach to producing nasopharyngeal carcinoma etc.The rhinitis disease is listed in one of difficult medical problem, in case fall ill, not only brings misery to patient, and also brings huge stress for the household.According to present traditional treatment rhinitis disease, the methods such as dripping medicine, laser, puncture flushing that adopt more, this method has certain antiinflammation to the sick inflammation of rhinitis, can only the respite symptom.Do not regulate immunity of organisms, particularly intractable rhinitis disease is not reached the effect of radical cure source of disease.
Summary of the invention
The present invention seeks to provides a kind of pharmaceutical composition for the treatment of rhinitis, sinusitis in order to overcome the shortcoming that existing rhinitis medicine and traditional treatment are cured the symptoms, not the disease.
The present invention seeks to be achieved through the following technical solutions:
The crude drug of pharmaceutical composition of the present invention consists of:
Fructus Xanthii 5-15 weight portion Flos Magnoliae 5-15 weight portion Scorpio 3-9 weight portion
Bombyx Batryticatus 3-9 weight portion Herba Asari 1.5-4.5 weight portion Herba Pogostemonis 3-9 weight portion
Rhizoma Paridis 5-15 weight portion Herba Andrographis 7-23 weight portion Radix Angelicae Dahuricae 7-23 weight portion.
The optimum ratio of pharmaceutical composition of the present invention is:
Fructus Xanthii 10 weight portion Flos Magnoliaes 10 weight portion Scorpios 6 weight portions
Bombyx Batryticatus 6 weight portion Herba Asaris 3 weight portion Herba Pogostemoniss 6 weight portions
The Rhizoma Paridis 10 weight portion Herba Andrographis 15 weight portion Radixs Angelicae Dahuricae 15 weight portions.
The optimum ratio of pharmaceutical composition of the present invention is:
Fructus Xanthii 6 weight portion Flos Magnoliaes 12 weight portion Scorpios 5 weight portions
Bombyx Batryticatus 4 weight portion Herba Asaris 2 weight portion Herba Pogostemoniss 8 weight portions
The Rhizoma Paridis 14 weight portion Herba Andrographis 20 weight portion Radixs Angelicae Dahuricae 10 weight portions.
The optimum ratio of pharmaceutical composition of the present invention is:
Fructus Xanthii 14 weight portion Flos Magnoliaes 8 weight portion Scorpios 4 weight portions
Bombyx Batryticatus 8 weight portion Herba Asaris 4 weight portion Herba Pogostemoniss 5 weight portions
The Rhizoma Paridis 6 weight portion Herba Andrographis 10 weight portion Radixs Angelicae Dahuricae 20 weight portions.
Described Flos Magnoliae is a Flos Magnoliae, and Bombyx Batryticatus is a Bombyx Batryticatus.
Pharmaceutical composition of the present invention adds the various dosage forms that conventional adjuvant is made clinical acceptance by practice of pharmacy, as tablet, capsule, granule, powder, spray, tincture or liniment etc.
Pharmaceutical composition of the present invention is remarkable to treatment rhinitis, sinusitis and allergic rhinitis effect, has no side effect.
Following experimental example and embodiment are used to further specify but are not limited to the present invention.
Experimental example 1 one, clinical data
Medicine composite for curing 369 routine patients of the present invention, wherein male 166 people, age 13-36 year, the course of disease 1 month-3 years; Woman's 203 examples, age 12-39 year, the course of disease 1 month-4 years.
Two, Therapeutic Method
1, medicine is formed: Fructus Xanthii 10 grams, Flos Magnoliae 10 grams, Scorpio 6 grams, Bombyx Batryticatus 6 grams, Herba Asari 3 grams, Herba Pogostemonis 6 grams, Rhizoma Paridis 10 grams, Herba Andrographis 15 grams, the Radix Angelicae Dahuricae 15 grams.
2, usage and dosage: with said medicine routinely technology be ground into coarser powder, divide two bags, each 1 bag is sooner or later packed medicated powder in the osculum container into, pour boiled water, aim at vessel port with nose, steam is slowly sucked, each 15-30 minute, 10 days 1 courses of treatment, if do not cure 1 course of treatment, can be at interval 5 days, the 2nd course of treatment of row again.
Three, therapeutic outcome
The present invention treats 369 routine patients, cures 343 examples and accounts for 93%, and 19 examples that take a turn for the better account for 5%, invalid 7 examples account for 2%, wherein male 166 people, age 13-36 year, the course of disease 1 month-3 years is cured 154 people, and 7 people take a turn for the better, invalid 5 people, women 203 examples, age 12-39 year, the course of disease 1 month-4 years is cured 189 people, and 12 people take a turn for the better, invalid 2 people, total effective rate 98%.Three the course of treatment symptom do not have obvious changer for invalid.See the following form
Four, model case
Case 1: XX woman in Meng work in 24 years old is examined April 10 calendar year 2001
Have a stuffy nose headache and dizzy 2 years of patient is vexedly easily exerted hypomnesis, the red tongue with yellow fur wiry and frequent pulse, the People's Hospital, genital areas is diagnosed as sinusitis, and suggestion is operative treatment in hospital, examines because of I disagree with operation, give the present invention's " snuffing bag " 10 bags, sooner or later each 1 bag is packed medicated powder in the osculum container into, pours boiled water, aim at vessel port with nose, steam is slowly sucked, each 15-30 minute, when smoking to 7 days, the self-induction symptom subtracts greatly, headache and dizzy disappears in the time of 10 days, and nasal meatus is unobstructed, is solid curative effect, get 10 bags again, so far not recurrence.
Case 2: old XX 17 years old student of man JIUYUE in 2004 was examined on the 4th
Patient's stream yellow thick nasal discharge of having a stuffy nose, hypertrophic inferior turbinate is diagnosed as hypertrophic rhinitis through municipal hospital, the suggestion laser surgery treatment is examined because of patient father and mother disagree with, gives logical 10 bags of this bright snuffing smoked nose, sooner or later each 1 bag is packed medicated powder in the osculum container into, pours boiled water, aim at vessel port with nose, steam is slowly sucked, each 15-30 minute, the concha nasalis inferior of hypertrophy begins atrophy in the time of the 5th day, disappears substantially in 10 days, is solid curative effect, get 10 bags again, so far not recurrence.
Case 3: Lee XX 14 years old student of man December in 2004 was examined on the 21st
Patient's stuffy nose with watery discharge is met cold rnning and is weighed, and district institute of traditional Chinese medicine is diagnosed as allergic rhinitis, uses tincture of the present invention, and symptom disappears substantially after ten days, continues again to use 10 days, so far not recurrence.
Following embodiment all can realize the described effect of above-mentioned experimental example.
The specific embodiment
Embodiment 1:
Fructus Xanthii 10kg Flos Magnoliae 10kg Scorpio 6kg Bombyx Batryticatus 6kg
Herba Asari 3kg Herba Pogostemonis 6kg Rhizoma Paridis 10kg Herba Andrographis 15kg
Radix Angelicae Dahuricae 15kg
With said medicine routinely technology be ground into coarser powder, divide two bags, each 1 bag is sooner or later packed medicated powder in the osculum container into, pour boiled water, aim at vessel port, steam is slowly sucked, each 15-30 minute with nose, 10 days 1 courses of treatment, if do not cure for 1 course of treatment, can be at interval 5 days, the 2nd course of treatment of row again.
Embodiment 2:
Fructus Xanthii 6kg Flos Magnoliae 12kg Scorpio 5kg Bombyx Batryticatus 4kg
Herba Asari 2kg Herba Pogostemonis 8kg Rhizoma Paridis 14kg Herba Andrographis 20kg
Radix Angelicae Dahuricae 10kg
Said medicine adds conventional adjuvant by practice of pharmacy and makes spray.
Embodiment 3:
Fructus Xanthii 14kg Flos Magnoliae 8kg Scorpio 4kg Bombyx Batryticatus 8kg
Herba Asari 4kg Herba Pogostemonis 5kg Rhizoma Paridis 6kg Herba Andrographis 10kg
Radix Angelicae Dahuricae 20kg
Said medicine adds conventional adjuvant by practice of pharmacy and makes tincture.
Embodiment 4:
Fructus Xanthii 10kg Flos Magnoliae 10kg Scorpio 6kg Bombyx Batryticatus 6kg
Herba Asari 3kg Herba Pogostemonis 6kg Rhizoma Paridis 10kg Herba Andrographis 15kg
Radix Angelicae Dahuricae 15kg
Said medicine adds conventional adjuvant by practice of pharmacy and makes liniment.
Claims (10)
1. pharmaceutical composition for the treatment of rhinitis, sinusitis is characterized in that said composition is made up of following crude drug:
Fructus Xanthii 5-15 weight portion Flos Magnoliae 5-15 weight portion Scorpio 3-9 weight portion
Bombyx Batryticatus 3-9 weight portion Herba Asari 1.5-4.5 weight portion Herba Pogostemonis 3-9 weight portion
Rhizoma Paridis 5-15 weight portion Herba Andrographis 7-23 weight portion Radix Angelicae Dahuricae 7-23 weight portion.
2. pharmaceutical composition according to claim 1 is characterized in that said composition is made up of following crude drug:
Fructus Xanthii 10 weight portion Flos Magnoliaes 10 weight portion Scorpios 6 weight portions
Bombyx Batryticatus 6 weight portion Herba Asaris 3 weight portion Herba Pogostemoniss 6 weight portions
The Rhizoma Paridis 10 weight portion Herba Andrographis 15 weight portion Radixs Angelicae Dahuricae 15 weight portions.
3. pharmaceutical composition according to claim 1 is characterized in that said composition is made up of following crude drug:
Fructus Xanthii 6 weight portion Flos Magnoliaes 12 weight portion Scorpios 5 weight portions
Bombyx Batryticatus 4 weight portion Herba Asaris 2 weight portion Herba Pogostemoniss 8 weight portions
The Rhizoma Paridis 14 weight portion Herba Andrographis 20 weight portion Radixs Angelicae Dahuricae 10 weight portions.
4. pharmaceutical composition according to claim 1 is characterized in that said composition is made up of following crude drug:
Fructus Xanthii 14 weight portion Flos Magnoliaes 8 weight portion Scorpios 4 weight portions
Bombyx Batryticatus 8 weight portion Herba Asaris 4 weight portion Herba Pogostemoniss 5 weight portions
The Rhizoma Paridis 6 weight portion Herba Andrographis 10 weight portion Radixs Angelicae Dahuricae 20 weight portions.
5. according to the described pharmaceutical composition of one of claim 1-4, it is characterized in that described Flos Magnoliae is a Flos Magnoliae, Bombyx Batryticatus is a Bombyx Batryticatus.
6. according to the described pharmaceutical composition of one of claim 1-4, it is characterized in that said composition adds conventional adjuvant by practice of pharmacy and makes the tablet of clinical acceptance, capsule, granule powder, spray, tincture or liniment.
7. pharmaceutical composition according to claim 5 is characterized in that said composition adds conventional adjuvant by practice of pharmacy and makes the tablet of clinical acceptance, capsule, granule powder, spray, tincture or liniment.
8. according to the application of the described pharmaceutical composition of one of claim 1-4 in the medicine of preparation treatment rhinitis.
9. the application of pharmaceutical composition according to claim 8 is characterized in that described rhinitis is meant sinusitis, hypertrophic rhinitis or allergic rhinitis.
10. the application of pharmaceutical composition according to claim 5 in the medicine of preparation treatment rhinitis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2006101457626A CN101185719B (en) | 2006-11-16 | 2006-11-16 | Medicinal composition for treating rhinitis and nasosinusitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2006101457626A CN101185719B (en) | 2006-11-16 | 2006-11-16 | Medicinal composition for treating rhinitis and nasosinusitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101185719A CN101185719A (en) | 2008-05-28 |
| CN101185719B true CN101185719B (en) | 2010-06-02 |
Family
ID=39478476
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2006101457626A Expired - Fee Related CN101185719B (en) | 2006-11-16 | 2006-11-16 | Medicinal composition for treating rhinitis and nasosinusitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101185719B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106265927A (en) * | 2016-08-31 | 2017-01-04 | 吉林紫鑫药业股份有限公司 | A kind of pharmaceutical composition for treating rhinitis and nasosinusitis and allergic rhinitis |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1424065A (en) * | 2002-12-20 | 2003-06-18 | 唐宗园 | Medicine for nasal obstruction |
-
2006
- 2006-11-16 CN CN2006101457626A patent/CN101185719B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1424065A (en) * | 2002-12-20 | 2003-06-18 | 唐宗园 | Medicine for nasal obstruction |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101185719A (en) | 2008-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102512502B (en) | Traditional Chinese medicinal composition for treating rhinitis | |
| CN102048973B (en) | Medicament for treating cold | |
| CN101954062B (en) | Medicament for treating chronic pharyngitis | |
| CN104547790A (en) | Traditional Chinese medicine composition for treating rheumatic arthritis and preparation method thereof | |
| CN101693089A (en) | Traditional Chinese medicine compound for treating diseases of lung Qi obstruction and dyspnea chest discomfort and preparation method thereof | |
| CN103356877A (en) | Traditional Chinese medicine composition for treating orthopedic diseases | |
| CN101653529A (en) | Medicine for treating allergic rhinitis | |
| CN103223118B (en) | Traditional Chinese medicine composition for treating facial paralysis | |
| CN101966295A (en) | Medicament for treating chronic amygdalitis | |
| CN102512552A (en) | Traditional Chinese medicine composition for treating exogenous fever | |
| CN101185719B (en) | Medicinal composition for treating rhinitis and nasosinusitis | |
| CN1730065A (en) | Medicament for treating rhinitis | |
| CN103721082A (en) | Traditional Chinese medicinal composition for treating scapulohumeral periarthritis | |
| CN102988804A (en) | Chinese medicine composition for treating wind-heat type common cold | |
| CN102697902B (en) | Chinese medicine composition for treating chronic rhinitis | |
| CN102698073B (en) | Traditional Chinese medicine extract for treating allergic rhinitis | |
| CN104906188A (en) | External traditional Chinese medicine for treating rhinitis and preparation method of external traditional Chinese medicine | |
| CN101249205A (en) | Chinese medicine for curing cold and all lesion | |
| CN103989979A (en) | Traditional Chinese medicine composition for treating jaundice hepatitis | |
| CN102670950B (en) | Chinese medicinal oral liquid for treating cough and preparation method thereof | |
| CN103566219A (en) | Traditional Chinese medicine composition for treating cold | |
| CN102284035A (en) | Chinese composition for treating rhinitis | |
| CN102743437B (en) | Traditional Chinese medicine composition having function of clearing vivotoxin and preparing method thereof | |
| CN101884704B (en) | Traditional Chinese medicine for treating asthma | |
| CN101129554A (en) | Traditional Chinese medicine for treating sick headache |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100602 Termination date: 20121116 |